Navigation Links
Generex Provides Corporate Update
Date:8/2/2011

type="disc">
  • Strengthened Intellectual Property.  The Company was granted a new patent for its buccal drug delivery platform technologies from the Canadian Intellectual Property Office (Patent No. 2,354,148, a patent titled Aerosol Formulations for Buccal and Pulmonary Application) increasing the number of issued patents related to the Company's buccal drug delivery platform technologies to 162.  In addition, the Company received a Notice of Allowance from the United States Patent Office relating to an application making augmentative pharmaceutical composition claims for the Antigen Express AE37 immunotherapeutic cancer vaccine, which strengthens independent composition of matter claims directed to the AE37 peptide. The full term of the new patent will extend through January 5, 2028.

    • Presented and Published Clinical Results at Leading Conferences and Publications.  The Company presented its clinical data at leading scientific conferences such as at the 33rd Annual San Antonio Breast Cancer Symposium, the 4th International Congress on Pre-Diabetes and the Metabolic Syndrome in Madrid, Spain, and the 7th Annual Clinical Diabetes Technology Meeting in Philadelphia, PA.  Studies have also been recently published in world-recognized publications such as Expert Review of Vaccines, the peer-reviewed scientific journal Diabetes, Obesity and Metabolism, and the international peer-reviewed journal Hormone and Metabolism Research.  

    "We are pleased with the developments that have been achieved to date," said Dr. Anderson.   "We are aggressively focused on implementing the strategic development plan and we are excited about the future prospects that lie ahead for Generex and its shareholders."

    About Generex Biotechnology Corporation

    Generex is engaged in the research, development, and commercialization of
    '/>"/>

    SOURCE Generex Biotechnology Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
    2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
    3. Generex Announces Presentations of Novel Vaccine Strategies
    4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
    5. Generex Announces Sales Agreement with Elias Shaker & Company
    6. Generex Presents Abstract at EASD Annual Meeting
    7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
    8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
    9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
    10. Generex Provides Clarification for Special Meeting Voting
    11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)...  The International Trade Commission (ITC) issued its final decision ... In a notice issued on December 23, the ITC ruled ... its humidifier was invalid. BMC President, James ... very excited with the ITC,s decision in this case. This ... since the very beginning on the key patents in the ...
    (Date:12/24/2014)... PuraMed BioScience®, Inc., (OTC Pink: PMBS), a ... healthcare products, announced it received the initial funding to ... headache relief product, for planned distribution to 1,000 medical ... , Washington State , and ... H Advanced headache relief gel formulation completed, PuraMed BioScience ...
    (Date:12/24/2014)... Mass. , Dec. 23, 2014   ... ), a biopharmaceutical company developing therapeutic products for ... Medicines Agency (EMA) of the Marketing Authorization Application ... EMA recently granted the company,s request for accelerated ... EMA,s regulatory review time.   The ...
    Breaking Medicine Technology:ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
    ... College of American Pathologists Outlines Recommendations at Food and Drug ... , ... increasing importance of laboratory tests in diagnosing and treating disease, representatives ... the Food and Drug Administration (FDA) urging increased oversight of laboratory ...
    ... CHICAGO and PASADENA, Calif. , July 20 ... that Huntington Memorial Hospital has selected the Allscripts ... Exchange (HIE) that enables physicians, hospitals and other health care providers ... team approach to patient care, regardless of where they are located ...
    Cached Medicine Technology:CAP Leaders Stress Need for Oversight of Direct-to-Consumer and Laboratory Developed Tests 2CAP Leaders Stress Need for Oversight of Direct-to-Consumer and Laboratory Developed Tests 3CAP Leaders Stress Need for Oversight of Direct-to-Consumer and Laboratory Developed Tests 4Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 2Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 3Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 4Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 5Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 6Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 7
    (Date:12/25/2014)... TX (PRWEB) December 26, 2014 ... Market Analysis to 2023” focuses on the current ... opportunities in the colorectal cancer market. Stivarga is ... of colon or rectal cancer. Boehringer Ingelheim is ... for the treatment of refractory CRC in the ...
    (Date:12/25/2014)... Product liability lawsuits filed in the ... http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal court, ... in the U.S. District Court, Northern District of Ohio ... conference on January 7, 2015, at the Paul G. ... Palm Beach, Florida. The Conference is scheduled to begin ...
    (Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of wedding dresses ... selection of black one-shoulder cocktail dresses . In addition, ... available at discounted prices, up to 70% off. ... three weeks only. You know, we have thousands of frequent ... our new items can visit our website for more details. ...
    (Date:12/25/2014)... The short film “Color of Honor” by young ... a true 9/11 hero, Welles Remy Crowther. It has been ... hours of Nuremberg International Short Film Festival and the 8th ... screenwriter and director Luciana Lagana plays the mother of ... husband, Gregory Graham - Graham plays a heroic ...
    (Date:12/25/2014)... 2014 BambooFlooringChina.com sells many bamboo products ... flooring. Today, the company announces big discounts on ... and colors. , BambooFlooringChina.com is the world’s leader in ... is valid until Jan. 20, 2015. , The bamboo ... with a natural thread. All the bamboo strips for ...
    Breaking Medicine News(10 mins):Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
    ... doctor and his wife for allegedly conducting large-scale illegal abortions ... Singh Amarjit Kaur had been carrying out the operations at ... get rid of female foetuses. ,Their illegal activities ... attendant with them tipped off police, district police chief Pramod ...
    ... of female foeticides in the state, the Rajasthan government ... Udaipur-based private hospital// for violating the Medical Termination of ... Tuesday night after a week-long investigation into the three ... Udaipur's Fatehsagar Lake Aug 1. ,"We have decided to ...
    ... that pre-menopausal women who are exposed to second hand smoke, ... that was a collaborative effort by researchers from the Harvard ... of Chinese researchers, was conducted on 14,000 men, pre and ... measured the mineral density of the hipbone and had taken ...
    ... unmarried have a considerably higher risk of dying early, even ... overweight especially later on in their life. ,The ... of the University of California, had involved the census and ... US. The study had shown that there was a higher ...
    ... breakthrough in breast cancer in years with the first ... ,Researchers from the Queens land Institute of Medical ... on more than 40, 000 women in Australia, Europe ... genes with a 10% increased risk of developing breast ...
    ... repeat itself and the campaign that took place eight years ... Pavilion// in Lauriston looks set to repeated again. NHS Lothian ... John's in Livingston, a situation that would force Edinburgh people ... treatment. ,In 1998, about 100,000 people signed the ...
    Cached Medicine News:Health News:Second-hand Smoke Could Increase The Risk Of Osteoporosis In Pre-menstrual Women 2Health News:Study finds Unmarried Or Single Persons Stand The Risk Of Dying Early 2
    ... 1939, AMT has become one of ... clinical laboratory practitioners and other allied ... Medical Technologists, Medical Laboratory Technicians, Office ... Medical and Dental Assistants and Allied ...
    ... An enzyme linked immunosorbent ... detection and semiquantitation of ... antibodies in human serum. ... antibodies can be used ...
    An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) of IgM isotype in human serum....
    An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
    Medicine Products: